 CLEVELAND, Sept. 02, 2021 GLOBE NEWSWIRE -- Vitality Biopharma, Inc. OTC Mkts: VBIO Vitality or the Company, an innovation-driven drug development company dedicated to unlocking the therapeutic powers of cannabinoids, today announced that the Securities and Exchange Commission has declared the Companys Form S-1 registration statement effective. The registration statement was filed pursuant to the Securities Purchase Agreement, dated as of August 19, 2021, entered into by the Company with Triton Funds LP Triton and its affiliate, Triton Funds LLC. The registration statement registers for resale the securities to be issued to Triton under an equity line financing of up to 5,000,000. Only Triton may use the related prospectus to resell the shares registered under the registration statement. 